Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7023

1.

Ghrelin: A link between aging, metabolism and neurodegenerative disorders.

Stoyanova II.

Neurobiol Dis. 2014 Aug 27. pii: S0969-9961(14)00257-5. doi: 10.1016/j.nbd.2014.08.026. [Epub ahead of print]

PMID:
25173805
[PubMed - as supplied by publisher]
2.

B vitamin polymorphisms and behavior: Evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline.

Mitchell ES, Conus N, Kaput J.

Neurosci Biobehav Rev. 2014 Aug 27. pii: S0149-7634(14)00204-8. doi: 10.1016/j.neubiorev.2014.08.006. [Epub ahead of print] Review.

PMID:
25173634
[PubMed - as supplied by publisher]
3.

Imaging Proteomics for Diagnosis, Monitoring and Prediction of Alzheimer's Disease.

Nazeri A, Ganjgahi H, Roostaei T, Nichols T, Zarei M; for the Alzheimer’s Disease Neuroimaging Initiative.

Neuroimage. 2014 Aug 27. pii: S1053-8119(14)00715-0. doi: 10.1016/j.neuroimage.2014.08.041. [Epub ahead of print]

PMID:
25173418
[PubMed - as supplied by publisher]
4.

Imaging Frontotemporal Lobar Degeneration.

Diehl-Schmid J, Onur OA, Kuhn J, Gruppe T, Drzezga A.

Curr Neurol Neurosci Rep. 2014 Oct;14(10):489.

PMID:
25171901
[PubMed - as supplied by publisher]
5.

Relationship between Serum Levels of Tau Fragments and Clinical Progression of Alzheimer's Disease.

Henriksen K, Byrjalsen I, Christiansen C, Karsdal MA.

J Alzheimers Dis. 2014 Aug 28. [Epub ahead of print]

PMID:
25171717
[PubMed - as supplied by publisher]
6.

Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype.

Riese F, Gietl A, Zölch N, Henning A, O'Gorman R, Kälin AM, Leh SE, Buck A, Warnock G, Edden RA, Luechinger R, Hock C, Kollias S, Michels L.

Neurobiol Aging. 2014 Jul 29. pii: S0197-4580(14)00499-0. doi: 10.1016/j.neurobiolaging.2014.07.030. [Epub ahead of print]

PMID:
25169676
[PubMed - as supplied by publisher]
7.

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.

Babić M, Svob Štrac D, Mück-Šeler D, Pivac N, Stanić G, Hof PR, Simić G.

Croat Med J. 2014 Aug 28;55(4):347-365. Review.

PMID:
25165049
[PubMed - as supplied by publisher]
8.

Development of Isotope Labeling Liquid Chromatography Mass Spectrometry for Mouse Urine Metabolomics: Quantitative Metabolomic Study of Transgenic Mice Related to Alzheimer's Disease.

Peng J, Guo K, Xia J, Zhou J, Yang J, Westaway D, Wishart DS, Li L.

J Proteome Res. 2014 Aug 28. [Epub ahead of print]

PMID:
25164377
[PubMed - as supplied by publisher]
9.

Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease.

Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O; for the Alzheimer’s Disease Neuroimaging Initiative.

JAMA Psychiatry. 2014 Aug 27. doi: 10.1001/jamapsychiatry.2014.1060. [Epub ahead of print]

PMID:
25162367
[PubMed - as supplied by publisher]
10.

Predicting the disease of Alzheimer with SNP biomarkers and clinical data using data mining classification approach: decision tree.

Erdoğan O, Aydin Son Y.

Stud Health Technol Inform. 2014;205:511-5.

PMID:
25160237
[PubMed - in process]
11.

Evaluation of Visinin-Like Protein 1 Concentrations in the Cerebrospinal Fluid of Patients with Mild Cognitive Impairment as a Dynamic Biomarker of Alzheimer's Disease.

Mroczko B, Groblewska M, Zboch M, Muszyński P, Zajkowska A, Borawska R, Szmitkowski M, Kornhuber J, Lewczuk P.

J Alzheimers Dis. 2014 Aug 26. [Epub ahead of print]

PMID:
25159667
[PubMed - as supplied by publisher]
12.

Plasma Protein Profiling of Mild Cognitive Impairment and Alzheimer's Disease Across Two Independent Cohorts.

Muenchhoff J, Poljak A, Song F, Raftery M, Brodaty H, Duncan M, McEvoy M, Attia J, Schofield PW, Sachdev PS.

J Alzheimers Dis. 2014 Aug 26. [Epub ahead of print]

PMID:
25159666
[PubMed - as supplied by publisher]
13.

Amyotrophic Lateral Sclerosis: A Focus on Disease Progression.

Calvo AC, Manzano R, Mendonça DM, Muñoz MJ, Zaragoza P, Osta R.

Biomed Res Int. 2014;2014:925101. Epub 2014 Aug 3. Review.

PMID:
25157374
[PubMed - as supplied by publisher]
Free PMC Article
14.

The characterization of biological rhythms in mild cognitive impairment.

Ortiz-Tudela E, Martinez-Nicolas A, Díaz-Mardomingo C, García-Herranz S, Pereda-Pérez I, Valencia A, Peraita H, Venero C, Madrid JA, Rol MA.

Biomed Res Int. 2014;2014:524971. doi: 10.1155/2014/524971. Epub 2014 Jul 17.

PMID:
25157363
[PubMed - in process]
Free PMC Article
15.

Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic.

Duits FH, Prins ND, Lemstra AW, Pijnenburg YA, Bouwman FH, Teunissen CE, Scheltens P, van der Flier WM.

Alzheimers Dement. 2014 Aug 21. pii: S1552-5260(14)02461-3. doi: 10.1016/j.jalz.2014.05.1753. [Epub ahead of print]

PMID:
25156643
[PubMed - as supplied by publisher]
16.
17.

Subjective Cognitive Complaints Contribute to Misdiagnosis of Mild Cognitive Impairment.

Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW.

J Int Neuropsychol Soc. 2014 Aug 26:1-12. [Epub ahead of print]

PMID:
25156329
[PubMed - as supplied by publisher]
18.

Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.

Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, Owenius R, Hägerström D, Wollmer P, Minthon L, Hansson O.

JAMA Neurol. 2014 Aug 25. doi: 10.1001/jamaneurol.2014.1358. [Epub ahead of print]

PMID:
25155658
[PubMed - as supplied by publisher]
19.

[Ethical considerations regarding the communication of diagnosis of prodromal Alzheimer's disease].

Serrano CM, Sorokin P, Taragano F.

Vertex. 2014 Mar-Apr;25(114):99-101. Spanish.

PMID:
25153975
[PubMed - in process]
20.

Alzheimer's disease biomarkers detection in human samples by efficient capturing through porous magnetic microspheres and labelling with electrocatalytic gold nanoparticles.

de la Escosura-Muñiz A, Plichta Z, Horák D, Merkoçi A.

Biosens Bioelectron. 2014 Aug 7. pii: S0956-5663(14)00589-2. doi: 10.1016/j.bios.2014.07.086. [Epub ahead of print]

PMID:
25153932
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk